Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-919.87%
operating margin TTM
-965.14%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.61 |
| peg ratio | -0.12 |
| price to book ratio | 0.94 |
| price to sales ratio | 10.21 |
| enterprise value multiple | -1.26 |
| price fair value | 0.94 |
profitability ratios | |
|---|---|
| gross profit margin | 77.63% |
| operating profit margin | -965.14% |
| pretax profit margin | -919.87% |
| net profit margin | -919.87% |
| return on assets | -96.96% |
| return on equity | -101.14% |
| return on capital employed | -116.09% |
liquidity ratio | |
|---|---|
| current ratio | 4.69 |
| quick ratio | 4.69 |
| cash ratio | 3.68 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 175.63 |
| cash conversion cycle | -175.63 |
| receivables turnover | 0.00 |
| payables turnover | 2.08 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.28 |
| debt equity ratio | 0.45 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.31 |
| interest coverage | -59.33 |
| cash flow to debt ratio | -3.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.46 |
| cash per share | 0.92 |
| operating cash flow per share | -1.46 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.03 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -371.73 |
Frequently Asked Questions
When was the last time Vor Biopharma Inc. (NASDAQ:VOR) reported earnings?
Vor Biopharma Inc. (VOR) published its most recent earnings results on 07-11-2024.
What is Vor Biopharma Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vor Biopharma Inc. (NASDAQ:VOR)'s trailing twelve months ROE is -101.14%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vor Biopharma Inc. (VOR) currently has a ROA of -96.96%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VOR's net profit margin stand at?
VOR reported a profit margin of -919.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VOR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.69 in the most recent quarter. The quick ratio stood at 4.69, with a Debt/Eq ratio of 0.45.